Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases
- PMID: 64293
- DOI: 10.1002/1097-0142(197701)39:1<232::aid-cncr2820390137>3.0.co;2-y
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases
Abstract
The clinical features of 57 autopsied cases of intrahepatic bile duct carcinoma including 28 cases of the peripheral type (cholangiocarcinoma in the narrow sense) and 29 cases of the hilar type are described in comparison with those of hepatocellular carcinoma, with a review of the literature on the clinicopathological aspects of intrahepatic bile duct carcinoma. As compared with hepatocellular carcinoma, the average age of the patients was older; the male predominance was not obvious, chronic parenchymal liver disease was infrequent in the past history, association of primary cirrhosis was seldom, cholestatic features were frequently the early signs and more pronounced during the course, the liver was enlarged to a lesser extent, ascites was less common, signs of portal hypertension were absent or minimal, and extrahepatic metastases were less frequent. In many respects, the hilar type resembled extrahepatic bile duct carcinoma, and the peripheral type was somewhat between it and hepatocellular carcinoma. Although the overall survival was not much different from that for hepatocellular carcinoma, early diagnosis is emphasized; this would make surgical management possible. Differential diagnosis from hepatocellular carcinoma may be possible in the majority with direct cholangiography, liver scan, celiac angiography, determination of alpha-fetoprotein and hepatitis B antigen, and blood chemistry such as SGOT, SLDH, serum bilirubin and alkaline phosphatase. Illustrative cases are given including one patient with a hilar carcinoma who survived for more than 2 years after transhepatic biliary drainage.
Similar articles
-
Independent occurrence of hepatocellular and cholangiocellular cancer nodules in the liver.Eur J Surg Oncol. 1987 Feb;13(1):69-73. Eur J Surg Oncol. 1987. PMID: 3028868
-
Long-term survival after liver transplant for recurrent hepatocellular carcinoma with bile duct tumor thrombus: case report.Exp Clin Transplant. 2012 Dec;10(6):614-7. doi: 10.6002/ect.2012.0022. Epub 2012 Jul 4. Exp Clin Transplant. 2012. PMID: 22765376
-
Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.J Hepatobiliary Pancreat Surg. 2006;13(6):537-42. doi: 10.1007/s00534-006-1117-1. Epub 2006 Nov 30. J Hepatobiliary Pancreat Surg. 2006. PMID: 17139428
-
Biliary tumors of the liver.Semin Liver Dis. 1995 Nov;15(4):402-13. doi: 10.1055/s-2007-1007290. Semin Liver Dis. 1995. PMID: 8578323 Review. No abstract available.
-
[A case of minute cholangiocellular carcinoma which was found in the follow-up periods of liver cirrhosis and was indistinguishable from hepatocellular carcinoma on hepatic angiography].Nihon Shokakibyo Gakkai Zasshi. 1991 Jun;88(6):1369-74. Nihon Shokakibyo Gakkai Zasshi. 1991. PMID: 1653864 Review. Japanese. No abstract available.
Cited by
-
Intrahepatic cholangiocarcinoma: clinicopathological differences between peripheral type and hilar type.J Gastrointest Surg. 2012 Mar;16(3):540-8. doi: 10.1007/s11605-011-1730-4. Epub 2011 Oct 20. J Gastrointest Surg. 2012. PMID: 22012305
-
Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma.J Cancer Res Clin Oncol. 2004 Jun;130(6):346-50. doi: 10.1007/s00432-003-0534-7. Epub 2004 Feb 28. J Cancer Res Clin Oncol. 2004. PMID: 14997381 Free PMC article. Clinical Trial.
-
FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma.J Clin Pathol. 2005 Dec;58(12):1249-54. doi: 10.1136/jcp.2005.026575. J Clin Pathol. 2005. PMID: 16311342 Free PMC article.
-
Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1467-72. doi: 10.1007/s00259-003-1297-8. Epub 2003 Aug 7. Eur J Nucl Med Mol Imaging. 2003. PMID: 14579085 Clinical Trial.
-
Prognostic factors in hilar cholangiocarcinoma.Ann Surg. 1997 Jul;226(1):107. doi: 10.1097/00000658-199707000-00026. Ann Surg. 1997. PMID: 9242344 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous